Case of bullous pemphigoid in patient with psoriasis, after new coronavirus infection COVID‑19
https://doi.org/10.33667/2078-5631-2021-27-48-51
Abstract
In this work we discuss a case of Bullosus pemfigoid (B.P.) developed after pneumonia caused by new coronavirus disease COVID‑19 in a patient with psoriasis. Provided description is supported with the data of histological and serologic analysis, the lgG of epithelial basement membrane was detected to antigen ВР230-CF and to antigen ВР180-NC16A.
About the Authors
N. S. Rudneva
Tula Regional Clinical Dermatovenerologic Dispensary; Tula State University
Russian Federation
Russian Federation
Tula
T. G. Sadunashvili
Tula Regional Clinical Dermatovenerologic Dispensary
Russian Federation
Russian Federation
Tula
Ya. Yu. Chumakova
Tula Regional Clinical Dermatovenerologic Dispensary
Russian Federation
Russian Federation
Tula
E. V. Natarova
Tula Regional Clinical Dermatovenerologic Dispensary
Russian Federation
Russian Federation
Tula
A. V. Losev
Tula Regional Clinical Hospital
Russian Federation
Russian Federation
Tula
References
1. Interim guidelines ‘Prevention, diagnosis and treatment of new coronavirus infection (COVID 19) version 11 (05/07/2021)’.
2. Sanchez A, Sohier P, Benghane S et al. Digitate Papulosguamous Eruption Associated with Severe Acute Respiratory Syndrome Coronavirus 2 Infection. JAMA Dermatol. Published online April 30, 2020. DOI: 10.1001/jamadermatol. 2020. 1704.
3. Estebanez A, Perez-Santiago L, Silva E et al. Cutaneous manifestations in COVID 19: a new contribution. J Eur Acad Dermatol Venereol 2020. DOI: 10.1111/ jdv.16474.
4. Recalcati S. Cutaneous Manifestations in COVID 19: a first perspective. J Eur Acad Dermatol Venereol. 2020. https://doi.org/10.1111/jdv.16387
5. Galván Casas C. et al. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases. British Journal of Dermatology. 2020. Т. 183. No. 1. P. 71–77.
6. Plavunov N. F., Kadyshev V.A., Sidorov A.M. et al. Cutaneous manifestations in patients with COVID 19 in the practice of emergency and emergency medical care. Archive of Internal Medicine. 2020; 10 (3): 223–229. DOI: 10.20514/2226– 6704–2020–10–3–223–229.
7. Dvornikov A.S., Silin A.A., Gaidina T.A. et al. Cutaneous manifestations in coronavirus disease 2019 (COVID 19). Archive of Internal Medicine. 2020; 10 (6): 422–429. DOI: 10.20514/2226–6704–2020–10–6–422–429.
8. Interim guidelines ‘Prevention, diagnosis and treatment of new coronavirus infection (COVID 19) version 8 (03.07.2020)’.
9. Bierle DM, Aakre CA, Grach SL, Salonen BR, Croghan IT, Hurt RT, Ganesh R. Central Sensitization Phenotypes in Post Acute Sequelae of SARS-CoV 2 Infection (PASC): Defining the Post COVID Syndrome. J Prim Care Community Health. 2021 JanDec; 12: 21501327211030826. DOI: 10.1177/21501327211030826. PMID: 34231404; PMCID: PMC8267019.
10. Kamal M, Abo Omirah M, Hussein A, Saeed H. Assessment and characterisation of post-COVID 19 manifestations. Int J Clin Pract. 2021 Mar; 75 (3): e13746. DOI: 10.1111/ijcp.13746. Epub 2020 Nov 3. PMID: 32991035; PMCID: PMC7536922.
11. Roth NC, Kim A, Vitkovski T, Xia J, Ramirez G, Bernstein D, Crawford JM. PostCOVID 19 Cholangiopathy: A Novel Entity. Am J Gastroenterol. 2021 May 1; 116 (5): 1077–1082. DOI: 10.14309/ajg.0000000000001154. PMID: 33464757.
12. Wijeratne T, Crewther S. Post-COVID19 Neurological Syndrome (PCNS); a novel syndrome with challenges for the global neurology community. J Neurol Sci. 2020 Dec 15; 419: 117179. DOI: 10.1016/j.jns.2020.117179. Epub 2020 Oct 13. PMID: 33070003; PMCID: PMC7550857.
13. El Sayed S, Shokry D, Gomaa SM. Post-COVID 19 fatigue and anhedonia: A cross-sectional study and their correlation to post-recovery period. Neuropsychopharmacol Rep. 2021 Mar; 41 (1): 50–55. DOI: 10.1002/npr2.12154. Epub 2020 Dec 17. PMID: 33332756; PMCID: PMC8182964.
14. Aguilar-Gamboa FR, Cubas-Alarcon D, Villegas-Chiroque M, Failoc-Rojas VE. Pityriasis rubra pilaris post-infection due COVID 19: case report. Colomb Med (Cali). 2021 Mar 18; 52(1): e7014577. DOI: 10.25100/cm.v52i1.4577. PMID: 33911322; PMCID: PMC8054706.
15. Klaus V. Fitzpatrick’s dermatology in clinical practice in 3 volumes. Klaus Wolf, Lowell A., Goldsmith, Steven I. [et al.] M.: Panfilova. 2015. Vol. 1.
16. Mazurov V.I. Clinical rheumatology. M.: E-noto, 2021.
17. Federal clinical guidelines ‘Psoriasis’ RODViK 2020; https://cr.minzdrav.gov.ru. Date of visit to the site: 27.08.21.
Review
For citations:
Rudneva N.S., Sadunashvili T.G., Chumakova Ya.Yu., Natarova E.V., Losev A.V. Case of bullous pemphigoid in patient with psoriasis, after new coronavirus infection COVID‑19. Medical alphabet. 2021;(27):48-51. (In Russ.) https://doi.org/10.33667/2078-5631-2021-27-48-51
Views:
420
Email this article 